ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000844.1|Clavulanic_1 # 3 # 128 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.730	BGC0000844.1|Clavulanic_1 	3	128	+	Loose	750	20.7866	bmr	36.36	3003007	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; nucleoside antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GACCAGGACCCCGAGACGGGGATCGCCGTCCTGCTCGACGCCACTCCCCCGCCCGAGCTGCACGAGTCGGCCCGGCTCTGTGCCGAGCTGTGCCCGTGCGAGGCCATCACGGTCACCGAGGGCTAG	DQDPETGIAVLLDATPPPELHESARLCAELCPCEAITVTEG	MEKKNITLTILLTNLFIAFLGIGLVIPVTPTIMNELHLSGTAVGYMVACFAITQLIVSPIAGRWVDRFGRKIMIVIGLLFFSVSEFLFGIGKTVEMLFISRMLGGISAPFIMPGVTAFIADITTIKTRPKALGYMSAAISTGFIIGPGIGGFLAEVHSRLPFFFAAAFALLAAILSILTLREPERNPENQEIKGQKTGFKRIFAPMYFIAFLIILISSFGLASFESLFALFVDHKFGFTASDIAIMITGGAIVGAITQVVLFDRFTRWFGEIHLIRYSLILSTSLVFLLTTVHSYVAILLVTVTVFVGFDLMRPAVTTYLSKIAGNEQGFAGGMNSMFTSIGNVFGPIIGGMLFDIDVNYPFYFATVTLAIGIALTIAWKAPAHLKAST	10.54	gnl|BL_ORD_ID|1152|hsp_num:0	1256			60	159	acriflavine; puromycin; chloramphenicol
BGC0000844.1|Clavulanic_2 # 365 # 1738 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.717	BGC0000844.1|Clavulanic_2 	365	1738	+	Loose	550	47.3654	VEB-4	22.7	3002373	protein homolog model	n/a	n/a	monobactam; cephalosporin	antibiotic inactivation	VEB beta-lactamase	ATGAAGAAAGCTGATTCCGTCCCGACCCCGGCTGAGGCGGCCCTCGCCGCCCAGACCGCGCTCGCGGCCGACGACTCCCCCATGGGCGACGCGGCCCGCTGGGCGATGGGGCTGCTGACCTCGTCCGGACTGCCCCGGCCGGAGGATGTGGCCGCGCGCTTCATCCCCACCTTCGCGGCGGCGGGGAACTTCGCGGAGACCGTGCGGGAGTGGCGGTCGAAGGGCCCCTTCACGGTCCGGGCCTACCACCCCGTCGCGCACAAGGGCTGGGTCGTGCTGTCGGCCCCGGCCGGGGTGCGGTACATCCTGTCGCTGACGCTGGACTCCAGCGGGCTGATCCGCATCCTCACCCTGAAGCCCGAGACCGTCATACCCGACATGGTCACGTGGAACGATGTCGAGGAGACCCTCCACACCCCGGGTGTGCAGCACTCCGTGTACGCGGTGCGGCTGACGCCCGACGGGCACGAGGTGCTGCACGCGTCGGCGCCGGAGCGGCCGATGCCGACCGGGTCGGCGTACAAGCTCTATCTGATGCGCGCGCTCGTCGCCGAGATCGAGAAGGGGACGGTGGGCTGGGACGAGATCCTCACGCTCACGCCCGAGCTGCGCAGCCTGCCCACGGGCGATATGCAGGACCTCCCCGACGGCACCCGGGTGACCGTGCGGGAGACCGCGCACAAGATGATCGCGCTGAGCGACAACACCGGCGCCGATCTGGTCGCGGACCGGCTGGGCCGGGAGGTCGTGGAGCGCTCCCTGGCAGCCGCGGGCCACCACGACCCGTCCCTGATGCGCCCGTTCCTCACCAGCCACGAGGTCTTCGAGCTGGGCTGGGGCGACCCGGAGCGGCGCGCGGAGTGGGTCCGGCAGGACGAGGCGGGCCGCCGGGAGCTGCTGGAGAAGATGGCCGGGGTGATGACCGTCCGCGGCTCCGACCTGGGCGCGACGGTCCATCAGCTCGGCATCGACTGGCACATGGACGCCTTCGACGTGGTCCGGGTGCTGGAGGGGCTGCTCCAGGACAGCGGACGGGACACCAGCGGCACGGTCGAGGAGATCCTCACCGCCTACCCCGGTCTGCTGATCGACGAGGAGCGCTGGCGCCGGGTCTACTTCAAGGCCGGTTCCAGCCCCGGTGTGATGATGTTCTGCTGGCTGCTCCAGGACCACGCGGGCATCTCGTACGTCCTCGTCCTGCGGCAGTCGGCCGACGAGCAGCGGCTCATCGGCGACGGTCTGTTCCTGCGCGGGATCGGCGCCAAGATCATCGAGGCCGAGGCGAAGCTGCTCAGCTCCGGTGAGCGCCGCGGTGCCGGGACCGCGGCGGCCGGGGACGACCGCGCGAGCGCCGGAGAAGCCGCCCGGCGATGA	MKKADSVPTPAEAALAAQTALAADDSPMGDAARWAMGLLTSSGLPRPEDVAARFIPTFAAAGNFAETVREWRSKGPFTVRAYHPVAHKGWVVLSAPAGVRYILSLTLDSSGLIRILTLKPETVIPDMVTWNDVEETLHTPGVQHSVYAVRLTPDGHEVLHASAPERPMPTGSAYKLYLMRALVAEIEKGTVGWDEILTLTPELRSLPTGDMQDLPDGTRVTVRETAHKMIALSDNTGADLVADRLGREVVERSLAAAGHHDPSLMRPFLTSHEVFELGWGDPERRAEWVRQDEAGRRELLEKMAGVMTVRGSDLGATVHQLGIDWHMDAFDVVRVLEGLLQDSGRDTSGTVEEILTAYPGLLIDEERWRRVYFKAGSSPGVMMFCWLLQDHAGISYVLVLRQSADEQRLIGDGLFLRGIGAKIIEAEAKLLSSGERRGAGTAAAGDDRASAGEAARR	MKIVKRILLVLLSLFFTIVYSNAQADNLTLKIENVLKAKNARIGVAIFNSNEKDTLKINNDFHFPMQSVMKFPIALAVLSEIDKGNLSFEQKIEITPQDLLPKMWSPIKEEFPNGTTLTIEQILNYTVSESDNIGCDILLKLIGGTDSVQKFLNANHFTDISIKANEEQMHKDWNTQYQNWATPTAMNKLLIDTYNNKNQLLSKKSYDFIWKIMRETTTGSNRLKGQLPKNTIVAHKTGTSGINNGIAAATNDVGVITLPNGQLIFISVFVAESKETSEINEKIISDIAKITWNYYLNK	152.84	gnl|BL_ORD_ID|560|hsp_num:0	613			189	612	
BGC0000844.1|Clavulanic_3 # 1735 # 2757 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=AGxAG;rbs_spacer=5-10bp;gc_cont=0.737	BGC0000844.1|Clavulanic_3 	1735	2757	+	Loose	500	28.4906	CTX-M-168	28.36	3005591	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	CTX-M beta-lactamase	ATGAGCGTCAGAGACCGGCTCCTCGCCTGCTTCGTGGCGGTGCTGTGGGGCCTGAACTTCCTCGCCGTGCGCATCGGCCTCGACTACTACCCTCCGGTGTTCCTCTCCGCGATGCGGTTCGTGGTCGTGGCCGTGCCGGTGATCCTCTTCGTGCCCCGGCCCAAGGTGCCCCTGCGCTGGCTGCTGGTGTACGGACTGGGCTTCGGTGTGATCCAGTTCGGGCTGCTCTTCCTCGCCATCGACATCGGCATGCCCTCGGGGCAGGCGTCCGTGGTGGTGCAGGCGGCGGCCCCGTTCACCATGCTGCTCGGGCTGCTGCTGGGGGAGCGCATCTCCCGGCGGCAGGCGGGCGGCATCGTGCTGGCCGTGGCCGGGATGAGCGCCATCGCGGTGGAACGGGCGCAGGACGCGGCCCTGCTGCCGCTGGTGCTGACCCTGGTGGCGGCGTTCGGCTGGGCGATGGGCAATATCGCGAGCCGGCAGGCCCGCCCGGACCATCCGCTGCGCTTCGCGCTCTGGATGTGTGTGCTGCCGCCGATCCCGCTGCTGGGCCTGTCGGCCGCCCTGGAGGGCCCGACGGCGGGCTGGCGGGCCCTCGGCGACTCGCTCACCTCCGGCGACCTCACCGGTCCGGTGGCGCTGCTGTACACGGCCCTCGCGGGCTCCGTGGTCGGCTCCGGGATCTGGAACACCCTGATGAAACGGTACGAGGCGGGCACCGTGGCGCCGTTCTCGATGCTGGTTCCGGTGGTCGCCGTCGCGGTCGCCACGATCTGGCTGGACGAGCGGCTGACCCTCTGGTCGGCGGTGTCCGGCGCGGCCGTGGTGCTGGGCGTGCTGGTGGGGACGACCCGGTCGCGCGCGGCCCGGGAGGCGGGCCCGCCCCCGGCCGCCGGAAGGCCGCCGAAGGCCCCGGCGGAACGCGGCCGGATGCTGCGGCGGCGCCCACCGGGGCCCGGGGACACGGGTCCCGATCAGTCGGACGGACCGGCCTCGGCGGTCCAGAACACCCAGCGGTCGTAG	MSVRDRLLACFVAVLWGLNFLAVRIGLDYYPPVFLSAMRFVVVAVPVILFVPRPKVPLRWLLVYGLGFGVIQFGLLFLAIDIGMPSGQASVVVQAAAPFTMLLGLLLGERISRRQAGGIVLAVAGMSAIAVERAQDAALLPLVLTLVAAFGWAMGNIASRQARPDHPLRFALWMCVLPPIPLLGLSAALEGPTAGWRALGDSLTSGDLTGPVALLYTALAGSVVGSGIWNTLMKRYEAGTVAPFSMLVPVVAVAVATIWLDERLTLWSAVSGAAVVLGVLVGTTRSRAAREAGPPPAAGRPPKAPAERGRMLRRRPPGPGDTGPDQSDGPASAVQNTQRS	MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQVLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTMTLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEHTLNTAIPGDPRDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGSGDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL	116.84	gnl|BL_ORD_ID|3428|hsp_num:0	4497			330	528	
BGC0000844.1|Clavulanic_4 # 2709 # 3728 # -1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.753	BGC0000844.1|Clavulanic_4 	2709	3728	-	Loose	275	32.3426	AAC(6')-If	32.91	3002553	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	ATGAACGACACCGCCGGCGAACTGGAGTTCGTCCCCCTCGCGGCGAACGACGACGAAACGGTCGGCCAGTGGCTCGACCTGATGGCCCTCGCCGCCGAGACCGGCCCCCGGGCCGCGCCCCCCTGCAATGTCGACATGGTCGGCTCGCTGCGCTTCGCCCCGCCCGCGACCGCCCTCGACGACTGGGTCGTCCGCAGCGGGGGCCGGGTGGTGGGCGCGCTGCGGCTGGCCCTGCCCGACGGCGCCCCGACCGCCCGCGTCGACCAGCTCCTGGTCCACCCCGGGCGGCGCCGCCGCGGCATCGGCCGCGCGCTCTGGGCCCACGCCCGGGAACTGGCCCGCAAGCACGACCGGACCACCCTCACCGCGACCGTCGTCGAGTCCCTGCCCTCCGGCCCGGCCCAGGACCCGGGCCCGGCCGCCTTCGCCGCCGCGATGGGCGCGCACCGCTCGGACATCCCGGCGGGCACCCACCAGTGGCTCGACCTCGACCGGCACGACCCGCTGGCGGACGGCGTCCCCGCGGTCCCCGCCGGGTACTCCCTCGTCACCTGGGGCACCATCACCCCCGACGAGTACGCGGTGCCGGTCTCCGAGCTGGAACTCTCGCTCGGCGCCGGGCCCGTCGACAGGGCCGCGCAGGAGGTCAGGACGAGCTACGCCCGGCAGTTCGAGACCATGCGGGTCGGCCGCGGCCGGCGGGCGTACCACACCGGCGCCGTCCACGACGCCACCGGCGCTCTCGCCGGGTACACCAGCGTCTCCAAGACCACCGGGAACCCCGCGTACGCGCTCCAGGGCATGACCGTGGTGCACCGTGAGCACCGCGGCCACGCCCTGGGAACCCTGCTGAAGCTGGCCAATCTGGAGTACGTGCTGCGGCACGAGCCGGAGGTGCGGCTCGTGGAGACGGCGAACGCCGAGGACAACCACCCGATGATCGCCGTCAACGCCGCGCTGGGCTTCGAGCCCTACGACCGCTGGGTGTTCTGGACCGCCGAGGCCGGTCCGTCCGACTGA	MNDTAGELEFVPLAANDDETVGQWLDLMALAAETGPRAAPPCNVDMVGSLRFAPPATALDDWVVRSGGRVVGALRLALPDGAPTARVDQLLVHPGRRRRGIGRALWAHARELARKHDRTTLTATVVESLPSGPAQDPGPAAFAAAMGAHRSDIPAGTHQWLDLDRHDPLADGVPAVPAGYSLVTWGTITPDEYAVPVSELELSLGAGPVDRAAQEVRTSYARQFETMRVGRGRRAYHTGAVHDATGALAGYTSVSKTTGNPAYALQGMTVVHREHRGHALGTLLKLANLEYVLRHEPEVRLVETANAEDNHPMIAVNAALGFEPYDRWVFWTAEAGPSD	MDEASLSMWVGLRSQLWPDHSYEDHILDSQHILSCPDKYVSFLAINNQSQAIAFADAAVRHDYVNGCESSPVVYLEGIFVIPEQRGHGVAKLLVAAVQDWGVAKGCTEMASDAALDNHISYQMHQALGFEETERVVFFRKRIAG	235.42	gnl|BL_ORD_ID|1520|hsp_num:0	1651			189	414	dibekacin; amikacin; sisomicin; netilmicin; tobramycin; 2'-N-ethylnetilmicin; 5-episisomicin
BGC0000844.1|Clavulanic_5 # 3822 # 5510 # -1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.735	BGC0000844.1|Clavulanic_5 	3822	5510	-	Loose	550	27.7202	BEL-3	34.62	3002387	protein homolog model	n/a	n/a	monobactam; cephalosporin; penam	antibiotic inactivation	BEL beta-lactamase	ATGACCACCGCCGCGCGACGACCGGCCCCGACGACCGCCGGAGCCGGCTGGGACGCCGGGGTGGGGGCGCTGGTGAACCCCTCGCGGCGGCGCGGCGGGACCCTGCGGCTCGTCTCCTCGGCCGACGTCGACTCCCTCGACCCGGCCCGCACCTACTACGTCTGGGTGTGGCTGCTCCAGCGGCTGCTGAACCGTACGCTCATGGCCTATCCGACCGACCCCGGCCCCGCCGGACTGGTCCCGGCCCCGGACCTGGCCGAGGGCCCCGGCGAGGTCAGCGACGGCGGCCGGACCTGGACCTACCGGCTGCGCCGGGGGCTGCGCTACGACGACGGCACCCCGATCACGTCGGACGATGTGCGCCACGCCGTGCAGCGGGTGTTCGCGCAGGACGTGCTGCCCGGCGGCCCCACCTATCTCATCCCGCTGCTGGACGACCCCGAGCGGCCCTACCCCGGTCCGTACCGGACGGACGAGCCGCTGCGGTCGGTCCTCACCCCCGACGAGCACACGATCGTCTTCCGGCTGACCCGGCCGTTCTCCGACTTCGACCATCTGATGGCCCAGCCCTGCGCGGCGCCCGTGCCCCGGCGCTCGGACACCGGCGCCGACTACGGCCGCGACCCGCGCTCGTCGGGCCCCTACCGGGTCGCCCGCCATGAGCCGGACACCCTGCTCCACCTGGAGCGCAATCCGCACTGGGACCGGGCGACGGACCCGATCAGGCCCGCGCTGCCGGACCGGGTGGAGCTGACCATCGGTCTGGACGTCGATGTCCTGGACGCCCGGCTGATCGCCGGGGAGTTCGACATCAACCTGGAGGGCCGGGGGCTCCAGCACGCGGCCCAGCGCCGGGCCACCGCGGACGAGGTGCTGCGCTCGCACACGGACAACCCCCGGACGAGCTTCCTCCACTTCGTTGCGATGCAGCCGCACATCCCCCCGTTCGACAATGTGCACGTACGCCGCGCGGTGCAGTACGCGGCGGACAAGATCCTGCTCCAGGACGCCCGCGGCGGCCCGGTCAACGGCGGCGACCTGACCACGGCGCTCTTCCCGCCCACCCTCCCCGCCCACCAGGACCTGGATCTGTACCCCACGGGGCCGGACCTCCGCGGCGACCTGGACGCGGCGCGGGCCGAGCTGGCGGCGGCGGGCCTCCCGGACGGCTTCCGGGCGGTGATCGGCACCCAGCGGGGCAAGTTCCGGCTGGTCGCCGACGCGGTCGTGGAGTCGCTCGCCCGGGTCGGCATCGAGCTGACCGTCAAGGAACTCGACGTCGCCACCTACTTCAGCCTCGGCGCCGGGCACCCCGAGACCGTCCGGGAGCACGGGCTCGGACTCCTCGTCACCGACTGGGGCGCCGACTTCCCCACCGAGTACGGCTTCCTCGCCCCGCTCGTGGACGGCCGCCAGATCAAGCGCAACGGCGGCAACTGGAACCTGCCCGAGCTGGACGACCCCGAGGTCAACGCGCTGATCGACGAGACCCTGCACACCACCGACCCCGCCGCGCGCGCGGAGCTGTGGCGGGCCGTGGAGCGCCGGGTGATGGAGCACGCCGTGCTGCTGCCCCTCGTCCACGACAAGACGCTGCACTTCCGCAACCCGTGGGTCACCAACGTCTATGTCCACCCGGCCTTCGGCCTCTACGACATCCAGGCGATGGGCCTCGCCGAAGAAGACTAG	MTTAARRPAPTTAGAGWDAGVGALVNPSRRRGGTLRLVSSADVDSLDPARTYYVWVWLLQRLLNRTLMAYPTDPGPAGLVPAPDLAEGPGEVSDGGRTWTYRLRRGLRYDDGTPITSDDVRHAVQRVFAQDVLPGGPTYLIPLLDDPERPYPGPYRTDEPLRSVLTPDEHTIVFRLTRPFSDFDHLMAQPCAAPVPRRSDTGADYGRDPRSSGPYRVARHEPDTLLHLERNPHWDRATDPIRPALPDRVELTIGLDVDVLDARLIAGEFDINLEGRGLQHAAQRRATADEVLRSHTDNPRTSFLHFVAMQPHIPPFDNVHVRRAVQYAADKILLQDARGGPVNGGDLTTALFPPTLPAHQDLDLYPTGPDLRGDLDAARAELAAAGLPDGFRAVIGTQRGKFRLVADAVVESLARVGIELTVKELDVATYFSLGAGHPETVREHGLGLLVTDWGADFPTEYGFLAPLVDGRQIKRNGGNWNLPELDDPEVNALIDETLHTTDPAARAELWRAVERRVMEHAVLLPLVHDKTLHFRNPWVTNVYVHPAFGLYDIQAMGLAEED	MKLLLYPLLLFLVIPAFAQADFEHAISDLEAHNQAKIGVALVSENGNLIQGYRANERFAMCSTFKLPLAALVLSRIDAGEENPERKLHYDSAFLEEYAPAAKRYVATGYMTVTEAIQSALQLSDNAAANLLLKEVGGPPLLTKYFRSLGDKVSRLDRIESTLNTNTPGDERDTTTPMSMAQTVSKLIFGDTLTYKSKGQLRRLLIGNQTGDKTIRAGLPDSWVTGDKTGSCANGGRNDVAFFITTAGKKYVLSVYTNAPELQGEERALLIASVAKLARQYVVH	198.59	gnl|BL_ORD_ID|1766|hsp_num:0	1914			675	831	
BGC0000844.1|Clavulanic_6 # 5507 # 6712 # -1 # ID=1_6;partial=00;start_type=GTG;rbs_motif=GGxGG;rbs_spacer=5-10bp;gc_cont=0.750	BGC0000844.1|Clavulanic_6 	5507	6712	-	Loose	400	25.409	QnrA1	31.88	3002707	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic target protection	quinolone resistance protein (qnr)	GTGAGCGGAGACGCCACCCTGCCGGTGACGGACGCGCTGCCGCACACGGCGGCGGACGCGGTGACGGACGTGGTGGCGGTGCCCGACGCCGCCGCCCTCCCCACCAGCGGCTGGCCGGATCTCGTCGGCCCGGAGGACTTCTTCCAGACGCCCCGCTGGCTGGCGGTGCAGGAGCGCAACTCCGGCACCACGATGGACTTCCTGGTCCGCCGCCGCGCGGGCCGTCCCGTCGCGGCCCTGGTGACCGCGTGGGGCGACGACTCCGTGCCCTGGCTGCTGGCCCGCCCGGACGCGATGCTCACCCGGGCGCTGGAGGGCGAGGGGGAGCACCCCGAGGCCGAGGCCCGGCTCGCCGACACGGCCGGGGGAGACCCCGCCTCGCTGCTGCCCTCGCTGGTGTGCGGCGGCCGGCATCTGGGCCGCACCCGCCCGCTCGCCGCGCCCGACGCGCTGCCGTCCGACGTGGAGGCGCTGGTCGCCGAGGCCGAGCGGCTCGCGAAGGAGCGGGGCGCGGCCACCGTCTGCTTCCCGCACGTCGACGACCGCGACGGCGCCCTGATCGGGCTGCTGCGCTCGCGCGGCTATGTCTCGCACCCCTCGGCGCACTACGCCTGGCTCGACATCCCGCCCGGCGGCTGGGACGAGTTCCTGGCCGACATGACCAAGCACCGCCGCCGCCGGGTCCGGCTGGAGCGCCGGGCGCTGGACGCGGCGGGCATCGAGGTGCGGATCGAGCCGCTGACCCAGGAGATCGTGCCCCGGCTCGGCGAACTCGACTGCAATCTGCTGCGCAAGTACGGCAACCCGGCGAGCCCCGAGCACTCCGCGGGGCTGCTGAGCTGGATCGCCCAGGTCATGGGCGACGACGTGATGGTCTCCGTGGCCCGCAAGGACGGGGTGATCATCGGCTTCGGCATGGTGCTGCGCTCCCGGGCCCGGGGCCGCGAGGAGTGGTTCGGCCACCGCGCCGGATTCGACTACGAGGCCCAGGGCAGGCTGCCGCTCTACTACGACGTCCTGTACTACCGGGTGCTGGAGGCCGCCGCCCGCGAGGGCGTGACCGTGCTGCACGCCGGGATCGGCAGCGTCGAGGCGAAGCTGGCCCGCGGCTGTCTGGCCAGCCAGGAGCACTCGTTCCTGCTGCGCCTGCCGCGCACCGGGGAGACCGGCACCACCGACACCGATCAGAAGAGGACCGCACCATGA	MSGDATLPVTDALPHTAADAVTDVVAVPDAAALPTSGWPDLVGPEDFFQTPRWLAVQERNSGTTMDFLVRRRAGRPVAALVTAWGDDSVPWLLARPDAMLTRALEGEGEHPEAEARLADTAGGDPASLLPSLVCGGRHLGRTRPLAAPDALPSDVEALVAEAERLAKERGAATVCFPHVDDRDGALIGLLRSRGYVSHPSAHYAWLDIPPGGWDEFLADMTKHRRRRVRLERRALDAAGIEVRIEPLTQEIVPRLGELDCNLLRKYGNPASPEHSAGLLSWIAQVMGDDVMVSVARKDGVIIGFGMVLRSRARGREEWFGHRAGFDYEAQGRLPLYYDVLYYRVLEAAAREGVTVLHAGIGSVEAKLARGCLASQEHSFLLRLPRTGETGTTDTDQKRTAP	MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLQDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQVSHKMYFCSAYISGCNLAYTNLSGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD	183.94	gnl|BL_ORD_ID|1835|hsp_num:0	1987			456	651	ciprofloxacin; levofloxacin; moxifloxacin; gatifloxacin; nalidixic acid; norfloxacin; sparfloxacin
BGC0000844.1|Clavulanic_7 # 6709 # 8022 # -1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.715	BGC0000844.1|Clavulanic_7 	6709	8022	-	Loose	275	32.3426	vanN	35.0	3002912	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; Van ligase	ATGACCACACCCCTGGCCGACTATGCCAAGTTCGCGGGCAAGCGCATCGCGATCGTCGAGCACATGCAGAACCACCCCTTCGTCCTGGGGCTCCACCAGGCACGTGAGCACGGCCTTGAGGTCTGGCTGCTCACCGGGGACCGGTCCTGGTACACCCACGGGCACGACTGGGACAGCCACCCCCTCGCGGCGGCCGTCGACCGGGTGGTCGACGTGGACACCACCGATCTGGCGGCCGTGCTCGCGGCCGTCACCGACGAGAGCGGGCAGTGCCTGGTCGACGGGCTCACCTCGTTCTCCGACTACCACACGGTCATCGCCGCGCAGGCGGCCCAGCGGCTGTCGCTGCCCGGCCCCGACCCCGAGGCCGTGGAGACGGCGAACGAGAAGGACCGGCTGCGCCTCGCCCTCGGCGACGTCCCCTACAACATCCCGCACGCCCGGGTCAGCAGCCGCGAGCAGCTCGACGAGGCCGTACGGAAGCTCGGCTTCCCCATGATCGCCAAGCCGCCCGCCGAGGCCATCAGCTACGGGGTGCGCCGCGTCGACACCATGGCGGAGCTGGTCGAGGCGTACGAGGAGCTGTCCGGCGTCCGCCACAGCCTGCGCGGCCAGCCGCGCTCCGGCGATGTCCTCCTGGAGACCTATGTCGAGGGCGTCGAGGTCAGCGTCGAGACGATGACCGTGGACGGGTACACCCATGTCTTCGGGGTCACCTCCAAGGACCTGTTCGGCGACCCCGCGTACATCGAGTGCGGGCACACCTTCCCGGTGCCCCTCTCCGACGAGGAGCGCGAGGCGCTGTACGCCGCCGTCCGGGGCACCCTGGAGGCGATCGGCTACCGGCACGGCCCCTGCCACACCGAGGTGCGGCGCACCGAGACCGGCTGGCGGATCATCGAGGCCAACCCGCGCACCCCGTCGAGCTGTATGACGATGCTGGTCACCGATGTCACCGGGCGCAGCCCGATCCTCGACGCCTGGCTGCTGACGATCGGCGAGGCCCCGCCGATCGAGCCCGTCGTCCACAACGGCGGCGCCGCCGTGCGCATGATCTACCCGACCCGGAAGGGCACCCTCACCCGGGTCGACGGCATCGAGGCCGCGGCCGCGGTGCCCGGGGTCCAGGTGCTGCTGCACGTGGAGAAGGGCGACAAGCTGCTCCAGCGCATGGACAACTCCTCGTGCGTCGGCTTCACCTACTGCGCCGGGGCGGACCGGGAGGAGGCCCAGGCCCTCGCGGACCGCGCGGCCGGATACCTGGACTTCGTCGTCGAGGAGGACGAGCGGGGCGAGCGGGGCGGGGAGTCGTGA	MTTPLADYAKFAGKRIAIVEHMQNHPFVLGLHQAREHGLEVWLLTGDRSWYTHGHDWDSHPLAAAVDRVVDVDTTDLAAVLAAVTDESGQCLVDGLTSFSDYHTVIAAQAAQRLSLPGPDPEAVETANEKDRLRLALGDVPYNIPHARVSSREQLDEAVRKLGFPMIAKPPAEAISYGVRRVDTMAELVEAYEELSGVRHSLRGQPRSGDVLLETYVEGVEVSVETMTVDGYTHVFGVTSKDLFGDPAYIECGHTFPVPLSDEEREALYAAVRGTLEAIGYRHGPCHTEVRRTETGWRIIEANPRTPSSCMTMLVTDVTGRSPILDAWLLTIGEAPPIEPVVHNGGAAVRMIYPTRKGTLTRVDGIEAAAAVPGVQVLLHVEKGDKLLQRMDNSSCVGFTYCAGADREEAQALADRAAGYLDFVVEEDERGERGGES	MKKIALIFGGTSAEYEVSLKSAASVLSVLENLNVEIYRIGIASNGKWYLTFSDNETIANDLWLQDKKLNEITPSFDGRGFYDQAEKVYFKPDVLFPMLHGGTGENGTLQGVFECMQIPYVGCGVASSAICMNKYLLHQFAKSVGVMSTPTQLISSTDEQQVIKNFTELYGFPIFIKPNEAGSSKGISKVHTEAELTKALTEAFQFSQTVILQKAVSGVEIGCAILGNDQLLVGECDEVSLATDFFDYTEKYQMTTAKLTVPAKIPVATSREIKRQAQLLYQLLGCQGLARIDFFLTEAGEILLNEINTMPGFTNHSRFPAMMAATGITYQELISTLITLAEDK	127.41	gnl|BL_ORD_ID|143|hsp_num:0	164			507	660	vancomycin
BGC0000844.1|Clavulanic_8 # 8295 # 9779 # -1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.673	BGC0000844.1|Clavulanic_8 	8295	9779	-	Loose	1250	113.62	mecA	30.14	3000617	protein homolog model	n/a	n/a	penam	antibiotic target replacement	methicillin resistant PBP2	ATGAACAGGCCGCTGCGGCACATAGCCATCTTCTGCGGGCTGCTGACACTCGCGCTGCTGCTGAGAGCCAACTGGCTGCAGTACGTGGACGCCGAGGAACTGGCCACGCACGAGCGCAACCGCCGGGTCCAGATCAACCAGTTCGCGACCCCGCGCGGCGACATCATCGTGGGTGGCGGTACCTCCATCACCGGGTCGAAGGCCGTCGACGGCACCGACTTCAAGTACCAGCGCACCTACAAGAACGGCCCCATGTACGCGCCCGTCACCGGGTACGCCTCGCAGTCCATGGGCATGTCGCTGCTGGAGAACACGTTCGACAGCGTATTGAGCGGGCAGGACGACCGGCTCGCGATCCAGCGCTTCACCGACGTCGTCACCGGCAAGGACCGGCGCGGCGGCAATGTGATCACCACGATCGACCCCAAGGCGCAGCAGGCCGCGTACAAGGGGCTCACCGCCCTGGACGCCCGGGGCTCGGCCGTGGCGCTCGACCCGAAGACGGGCAAGGTGCTCGCCCTGGTCTCGACCCCGTCCTACGACCCCGGTGTCTTCGCGGGCAACAGCCTCAAGGAGAGCAAGCGGTTCCGGGACCTGGACAAGGACAAGGGCAAGCCGCTGGCCAACCGCGCGCTGCGGGAGACCTTCCCGCCCGGCTCCACGTTCAAGATCCTCACGGCGGCGGCGGCCCTGGAGCACGGGGTGATCGACGACATCGACGCGAAGACCGACGCGGTGTCCCCGTATCCGCTGCCGCAGTCGACCAACACGGTCGGCAGCGAGGCGGGCAACGCGGCCTGCGACAAGGTCTCGCTGAAGACCGCCATGCAGCATTCCTGCAACAATGTCTTCCTCGACGCCGCGGTCAAGCTGGGCGTGGACAAGATGCGCGACACCGCCGAGAAGTTCGGGTTCAACGAGGACGTCTACTCGGACGCCTTCGGCGACATGCGGGCCGTCAAGAGCCTGTACCCCAAGGAACTGGACAAGCCGGGCACCGCGCTGACCGGTATGGGACAGGGCAGCCTCACCAGCACCCCCTTGCAGATGGCCATGGTCACCGCCGCCATCGCCAACAACGGCAAGCTGATGCAGCCGTACATCGTCGACGAGGTGCAGTCCCCCGATCTGAGCACCCTGGAGAAGAACGAGCCCCGGGAGATGAGCCAGGCCGTCTCCGAGGAGACCGCGGGCAAGGTCCGGGAGATGATGGAGTTCACCGCCAGGGAGGGCAGCGCCCGCAAGGCGCTGATCGACGGCGTCACGGTGGGCGGCAAGACCGGTACCGCGCAGCGCGGTGTCGATGTGCGCGAGCAGGTCCCGTACGGCTGGTTCGTCTCCTACGGGGAGAAGGACGGCCAGTCCGTGGCGGTGGCCGTCTTCATCGACCCGACCGCGATGGACATCTCCCGTGAGGACATCTCCGGCGGCGGTCTGGGCGCGCCCATCGCCCGCAGTGTGATGAAGGCCGTCCTGGAGAAGTGA	MNRPLRHIAIFCGLLTLALLLRANWLQYVDAEELATHERNRRVQINQFATPRGDIIVGGGTSITGSKAVDGTDFKYQRTYKNGPMYAPVTGYASQSMGMSLLENTFDSVLSGQDDRLAIQRFTDVVTGKDRRGGNVITTIDPKAQQAAYKGLTALDARGSAVALDPKTGKVLALVSTPSYDPGVFAGNSLKESKRFRDLDKDKGKPLANRALRETFPPGSTFKILTAAAALEHGVIDDIDAKTDAVSPYPLPQSTNTVGSEAGNAACDKVSLKTAMQHSCNNVFLDAAVKLGVDKMRDTAEKFGFNEDVYSDAFGDMRAVKSLYPKELDKPGTALTGMGQGSLTSTPLQMAMVTAAIANNGKLMQPYIVDEVQSPDLSTLEKNEPREMSQAVSEETAGKVREMMEFTAREGSARKALIDGVTVGGKTGTAQRGVDVREQVPYGWFVSYGEKDGQSVAVAVFIDPTAMDISREDISGGGLGAPIARSVMKAVLEK	MKKIKIVPLILIVVVVGFGIYFYASKDKEINNTIDAIEDKNFKQVYKDSSYISKSDNGEVEMTERPIKIYNSLGVKDINIQDRKIKKVSKNKKRVDAQYKIKTNYGNIDRNVQFNFVKEDGMWKLDWDHSVIIPGMQKDQSIHIENLKSERGKILDRNNVELANTGTAYEIGIVPKNVSKKDYKAIAKELSISEDYIKQQMDQNWVQDDTFVPLKTVKKMDEYLSDFAKKFHLTTNETKSRNYPLEKATSHLLGYVGPINSEELKQKEYKGYKDDAVIGKKGLEKLYDKKLQHEDGYRVTIVDDNSNTIAHTLIEKKKKDGKDIQLTIDAKVQKSIYNNMKNDYGSGTAIHPQTGELLALVSTPSYDVYPFMYGMSNEEYNKLTEDKKEPLLNKFQITTSPGSTQKILTAMIGLNNKTLDDKTSYKIDGKGWQKDKSWGGYNVTRYEVVNGNIDLKQAIESSDNIFFARVALELGSKKFEKGMKKLGVGEDIPSDYPFYNAQISNKNLDNEILLADSGYGQGEILINPVQILSIYSALENNGNINAPHLLKDTKNKVWKKNIISKENINLLTDGMQQVVNKTHKEDIYRSYANLIGKSGTAELKMKQGETGRQIGWFISYDKDNPNMMMAINVKDVQDKGMASYNAKISGKVYDELYENGNKKYDIDE	73.95	gnl|BL_ORD_ID|1216|hsp_num:0	1321			936	1893	methicillin
BGC0000844.1|Clavulanic_9 # 10386 # 12539 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=5-10bp;gc_cont=0.715	BGC0000844.1|Clavulanic_9 	10386	12539	+	Loose	1250	124.02	mecC	26.28	3001209	protein homolog model	n/a	n/a	penam	antibiotic target replacement	methicillin resistant PBP2	ATGAGCAATATCCCGGAGACCGGCCGGACTCCGAGGGTCCGGATACGGCTCGTGGTCGTCCAGATACTGGTGGTCTCCCTGCTGCTGACCCTCGGCGGCCGGCTCTGGCACCTCCAGATCCGGGAGGGCGAGCGGTACGCGGAGAAGGCGTCGGGGAACCGGGTCCAGCGGGTCGTCCAGCCCGCCGTGCGCGGCGCCATCCTCGACGCGCGCGGGGCCCCGATCGCGGACAACGAGACCCGGCTGGTCGTCTCCGCCTCCCGGACCGAGCTGCTGAAGGCGCCGGACCGGGGCAGGGCCGTGCTGACCCGGCTCGCCGGGGTCCTCGGCCTGCCCGCGCGGGAGCTGATGGACAAGGTCCGGCTGTGCGACAGCAAGACCCCCCGGCCCTGCTGGAACGGCTCGCCGTACCAGCCCATCCCGCTCACCGACGAGGCCACCGCCCGGCAGGCGCTCCAGATCCGCGAGCGCTCCGAGCAGTTCCCCGGCATCACCGCCGAGCCCACCGCCGTGCGCCGCTACCCCGGCCCCGGCGGCGCCAACACCGCGCAGGTACTCGGCTACCTCTCCCCCGTCACCGACGAGGAACTGCGGGCCGCGCAGACGTCCGACTCCCCCTACCTCCGCTCCGACCAGGTGGGGCGCAGCGGTCTGGAGCGGCAGTACGACGACATCCTGCGCGGCAGGGCGGGCATCACCGAATACGAGGTCGACCATCTCGGCCGGGTCATCGGCCGCTCCGGCGACACCCCCGCGACCCCCGGCGCCAACCTGATCACCAGCATCGACGCCCGGGTGCAGCGGATCGCCGAGTACGAGCTGAACGAGGCCATGAAGGCCGCCCGCAAGGACTGGGACCGCAACACCCGCAGGAACTACGAGGCCGACTCCGGCGCGGTCGTCGTGATGGAGGCGAGGACGGGCCGCATCGTCGCCATGGCGTCCAATCCGTCCTACGACCCCAACGCCTGGGTCGGCGGCATATCCGCCAAGGACTACCGGAAGCTCACCGGTGAGAACTCCAACCACCCGCTGCTGAACCGGGCGATCCAGGGCGTGGCGGCCCCCGGCTCGATCTTCAAGGTCATACCGACGGTGGCCGCCGTCAACGCGGGCTACCCCTTCGACGGGCGGTACGAGTGCTCCAGCTCGTACTCGATCGGCGGCCGGTCCTTCGGGAACTTCGAGTCCAAGGCGTACGGCCCCATCGACCTCGGCCGCGCCCTGGAGGTCTCCTGCGACACCGTGTACTACCGCCTCGCCCACGAGGAGTGGCGCAAGGACGGCGGCCTCACCCCGAAGAAGGGCGCGAAGGACTGGTTCTACAGGACCGCCCACCAGTTCGGCCTCGGGAAGACGACCGGCGTCGACCTGCCGAACGAGGTCACCGGCCGGGTCCCCGACCACCGGTGGAAGCAGGAGTACTGGGAGGCGAACAAGGACTCCTGGTGCGAGCACGGCAAGCGCGACGGCACCATGCTGGAGCAGTTCTCCTGGGAGAACTGCCGCCAGGGCAACCAGGTCCGCGCCGGTGACTCCGTGAACTACTCCATCGGCCAGGGCGACACCCTCACCACCCCCATCCAGATGGCGACGATCTACGCGGCCCTCGCCAACGGCGGCACCCTCTACACGCCGAGCGTGGGCAAGGCGGTCGTCAGCGCCGACGGCCGGAAGATCCGGGAGATCGAGCCGAAGGCGCACGGGAAGCTGCCCATGGACCGGGTGACCCGCGACAAGATGGACCAGGCCCTGGCCGGGGTCGCGACCGCCCGGGGCACGGCGGGCTGGCGGTTCGTCGGCTGGCCGCAGGAGCAGATCCCGATCCGGGCCAAGACGAGCACCGCCGAGGTCTTCGGCAAGCAGACCACCTCGTGGTTCGCCACCTACACCGACGACTACGCGGTCGTTCTGACGATCTCCCAGGGCGGTACGGGCTCCGGCGGCTCCGCCCCCGCCGTCCGCAAGATCTACAACGCGCTGTACGGCGTCGCGGAGGACGGCACCATCGACCGTTCCCGGGCGCTGCTCCCCACCCCGCAGCGGAAGCTGCCCGCGATCCGGCCCGACGGCTCCATCGACGCGCCGAGGATCCGGGCGTACCGGCCCGGGGCCGAGGGGCCCGCGGAGCGGCCCCTGCGGCGCGAGCCCTGA	MSNIPETGRTPRVRIRLVVVQILVVSLLLTLGGRLWHLQIREGERYAEKASGNRVQRVVQPAVRGAILDARGAPIADNETRLVVSASRTELLKAPDRGRAVLTRLAGVLGLPARELMDKVRLCDSKTPRPCWNGSPYQPIPLTDEATARQALQIRERSEQFPGITAEPTAVRRYPGPGGANTAQVLGYLSPVTDEELRAAQTSDSPYLRSDQVGRSGLERQYDDILRGRAGITEYEVDHLGRVIGRSGDTPATPGANLITSIDARVQRIAEYELNEAMKAARKDWDRNTRRNYEADSGAVVVMEARTGRIVAMASNPSYDPNAWVGGISAKDYRKLTGENSNHPLLNRAIQGVAAPGSIFKVIPTVAAVNAGYPFDGRYECSSSYSIGGRSFGNFESKAYGPIDLGRALEVSCDTVYYRLAHEEWRKDGGLTPKKGAKDWFYRTAHQFGLGKTTGVDLPNEVTGRVPDHRWKQEYWEANKDSWCEHGKRDGTMLEQFSWENCRQGNQVRAGDSVNYSIGQGDTLTTPIQMATIYAALANGGTLYTPSVGKAVVSADGRKIREIEPKAHGKLPMDRVTRDKMDQALAGVATARGTAGWRFVGWPQEQIPIRAKTSTAEVFGKQTTSWFATYTDDYAVVLTISQGGTGSGGSAPAVRKIYNALYGVAEDGTIDRSRALLPTPQRKLPAIRPDGSIDAPRIRAYRPGAEGPAERPLRREP	MKKIYISVLVLLLIMIIITWLFKDDDIEKTISSIEKGNYNEVYKNSSEKSKLAYGEEEIVDRNKKIYKDLSVNNLKITNHEIKKTGKDKKQVDVKYNIYTKYGTIRRNTQLNFIYEDKHWKLDWRPDVIVPGLKNGQKINIETLKSERGKIKDRNGIELAKTGNTYEIGIVPNKTPKEKYDDIARDLQIDTKAITNKVNQKWVQPDSFVPIKKINKQDEYIDKLIKSYNLQINTIKSRVYPLNEATVHLLGYVGPINSDELKSKQFRNYSKNTVIGKKGLERLYDKQLQNTDGFKVSIANTYDNKPLDTLLEKKAENGKDLHLTIDARVQESIYKHMKNDDGSGTALQPKTGEILALVSTPSYDVYPFMNGLSNNDYRKLTNNKKEPLLNKFQITTSPGSTQKILTSIIALKENKLDKNTNFDIYGKGWQKDASWGNYNITRFKVVDGNIDLKQAIESSDNIFFARIALALGAKKFEQGMQDLGIGENIPSDYPFYKAQISNSNLKNEILLADSGYGQGEILVNPIQILSIYSALENNGNIQNPHVLRKTKSQIWKKDIIPKKDIDILTNGMERVVNKTHRDDIYKNYARIIGKSGTAELKMNQGETGRQIGWFVSYNKNNPNMLMAINVKDVQNKGMASYNATISGKVYDDLYDNGKTQFDIDQ	107.82	gnl|BL_ORD_ID|742|hsp_num:0	810			720	1932	methicillin
BGC0000844.1|Clavulanic_10 # 12735 # 13901 # 1 # ID=1_10;partial=01;start_type=ATG;rbs_motif=AGGAGG;rbs_spacer=3-4bp;gc_cont=0.746	BGC0000844.1|Clavulanic_10 	12735	13901	+	Loose	275	26.1794	AAC(6')-Iq	30.23	3002560	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	ATGCAGACGGTCCCCGACTACCCCGGCCACACCTTCGCCGGGAGCCCCGTCCCGCTGCCCCGGGAACCCGTGGCCCGGGTGCGGCTGCCCAGCGGCGACACCGTCTGGCTGGTCACCGGGTACGAGGAGGTGCGCACCGCGCTGACCCATCCGCTGCTCTCCCGGCAGGTGGGCGCGGACGATCCGCAGGTGGGCTCGGCGGGGGTGATCGGCGGCGCCCGGGGCGGCGTACGGACCCTCCAGAGCGACGGGGCCGCGCACGGCGCGGTACGGCGGCTGGCGGCCCGGCCGTTCACCCCGCGCAGGGTCGCCCGGCTGCGGGAGCGCATCCAGGGGATCACCGACGGCCTCCTCGACACCATGGAGCGGTCCGGCTCCCCGGCGGACCTCGTCTCCTCGTTCGCGTATCCGCTGCCGATCACGGTGATCTGCGAGCTGTTCGCCGTGCCGGAGGGGGACCGGGCCCGCTTCGGCGTCTGGTCGGACCGGATCGTCACCCTGCTCGGCATCAGCGAGCAGGAGGTGGCCGACGCCCGGGACGCCCTCCAGGGCTATCTGCACGAGCTGGTGACCGCCCGGCGGGCCGAACCCGGCGACGATGTCGTCAGCGGCTGGCTGACGGCCGACGAGAACGGCGACCGGCTCACCGACGACGAGGTGGTCCGGCTCTCCCAGACGGTGATCATCGGCGGCTACGAGACGACCGTGAACTCCATCAGCGCCGGTATGTGGCGGCTCTTCCAGCACCCGGAGCAGCTCGCGGCGGTGCGCGCGGACCCCGGGCTGCTGCGCGGCACCGTCGAGGAGATCCTCCGGTATCAGCCGCAGGGGCTCTTCTTCCTGATCATGGTGGCCCGGGGCGATCTGGAGCTGGGCGGGGTGACCATCCGGGAGGGGGACGGGGTCATGCCGCTGCCCAACGCCGCCAACCGGGACGCCGCCCGCTTCGCCGACCCGGCCCGCTTCGACATCCACCGGCCGCCCGGCGGACATGTCGCCTTCGGCCATGGGGCGCACGCCTGTCTGGGCTCCGCGCTGGCCCGCATCGAGCTGGAGGTGGCGCTCGGGACGCTGCTCGGCCGCTTCCCGGGGCTGCGGCCCGCCGTCGCCGACCTGGACGAGCTGGCCTGGCGCGGCGACCGGCTGGTGTGCGGGCTGAGGGAGCTC	MQTVPDYPGHTFAGSPVPLPREPVARVRLPSGDTVWLVTGYEEVRTALTHPLLSRQVGADDPQVGSAGVIGGARGGVRTLQSDGAAHGAVRRLAARPFTPRRVARLRERIQGITDGLLDTMERSGSPADLVSSFAYPLPITVICELFAVPEGDRARFGVWSDRIVTLLGISEQEVADARDALQGYLHELVTARRAEPGDDVVSGWLTADENGDRLTDDEVVRLSQTVIIGGYETTVNSISAGMWRLFQHPEQLAAVRADPGLLRGTVEEILRYQPQGLFFLIMVARGDLELGGVTIREGDGVMPLPNAANRDAARFADPARFDIHRPPGGHVAFGHGAHACLGSALARIELEVALGTLLGRFPGLRPAVADLDELAWRGDRLVCGLREL	MDYSICDIAESNELILEAAKILRKSFLDAGNESWVDIKKAIEEVEDCIEHPNLCLGICLDDKLIGWTGLRPMYDKTWELHPMVIKTEYQCRGIGKVLIKELEKRAKGRGIIGIALGTDDEYQKTSLSMIDINERNIFDEIGNIKNVTNHPYEFYKKCGYMIVGIIPNANGKRKPDIWMWKDIS	212.57	gnl|BL_ORD_ID|1223|hsp_num:0	1327			78	207	dibekacin; amikacin; sisomicin; netilmicin; tobramycin; 2'-N-ethylnetilmicin; 5-episisomicin
